Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.34 is 18% above its 5-year average of 5.36, around the middle of its 5-year range (2.86–8.46).
As of the fiscal period ended Sunday, May 31, 2026. 0.50% above its 12-month average of 6.31.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-05-31): 6.34.
CURRENT RATIO
6.34
CURRENT RATIO AVG TTM
6.31
CURRENT RATIO AVG 3Y
5.37
CURRENT RATIO AVG 5Y
5.36
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.50%
CURRENT VS 3Y AVG
+18.13%
CURRENT VS 5Y AVG
+18.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+69.02%
vs the sector median at left
Market Cap
$2.28B
Current Ratio
3.48
TTM Avg
3.46
3Y Avg
3.68
5Y Avg
3.66
Market Cap
$2.40B
Current Ratio
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
Market Cap
$2.41B
Current Ratio
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$2.23B
Current Ratio
11.85
TTM Avg
5.21
3Y Avg
5.21
5Y Avg
5.21
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.34B | 6.34 | 6.31 | 5.37 | 5.36 |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 3.00 | 2.62 | 2.45 | 2.80 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 6.97 | 6.34 | 6.18 | 6.55 |
| Liquidia Corporation (LQDA)vs › | $2.30B | 2.31 | 2.92 | 5.50 | 6.00 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 3.48 | 3.46 | 3.68 | 3.66 |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | 24.14 | 21.55 | 17.24 | 12.65 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 1.50 | 1.54 | 1.54 | 1.56 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | 5.03 | 4.66 | 4.92 | 7.11 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.23B | 11.85 | 5.21 | 5.21 | 5.21 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.19B | 4.05 | 7.06 | 7.46 | 6.71 |
Current Ratio
6.34
Quick Ratio
6.34
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-05-31 | 6.34 |
| 2026-02-28 | 6.01 |
| 2025-11-30 | 7.02 |
| 2025-08-31 | 5.35 |
| 2025-05-31 | 6.82 |
| 2025-02-28 | 6.26 |
| 2024-11-30 | 6.46 |
| 2024-08-31 | 5.28 |
| 2024-05-31 | 5.57 |
| 2024-02-29 | 2.86 |
| 2023-11-30 | 3.40 |
| 2023-08-31 | 4.36 |
| 2023-05-31 | 4.01 |
| 2023-02-28 | 4.44 |
| 2022-11-30 | 4.51 |
| 2022-08-31 | 5.26 |
| 2022-05-31 | 4.22 |
| 2022-02-28 | 4.25 |
| 2021-11-30 | 4.70 |
| 2021-08-31 | 7.07 |
| 2021-05-31 | 8.46 |
| 2021-02-28 | 6.48 |
| 2020-11-30 | 6.70 |
| 2020-08-31 | 8.88 |
| 2020-05-31 | 5.72 |
| 2020-02-29 | 2.55 |
| 2019-11-30 | 2.44 |
| 2019-08-31 | 0.00 |
| 2019-05-31 | 0.00 |
| 2019-02-28 | 0.00 |
